Avoro Capital Advisors LLC
- SEC CIK
- 0001633313
Latest role at each company
- SCTX Scribe Therapeutics, Inc.Director, 10% Owner, Other: See Remarksas of Jul 28, 2026
- WHWK Whitehawk Therapeutics, Inc.Director, 10% Owner, Other: See remarksas of Jun 15, 2026
- CIK 000104207410% Owneras of Sep 14, 2023
Trades
Every Form 4 that lists Avoro Capital Advisors LLC as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| SCTXScribe Therapeutics, Inc. | Jul 28, 20269:30 PM ET | Jul 24 – Jul 28, 2026 | Avoro Capital Advisors LLC and 2 othersDirector, 10% Owner, Other: See Remarks | PPurchaseCommon Stock, par value $0.0001 per share | +2.39M | $15.1636 | +$36.26M | 3.09M | +342.8% | SEC |
| – | Sep 14, 202312:53 PM ET | Sep 12 – Sep 13, 2023 | Avoro Capital Advisors LLC and 1 other10% Owner | SSaleCommon Stock · Derivative | −300K | $0.0103 | −$3.09K | 950 | – | SEC |
| – | Sep 14, 202312:53 PM ET | Sep 12, 2023 | Avoro Capital Advisors LLC and 1 other10% Owner | PPurchaseCommon Stock · Derivative | +583.77K | $17.1299 | +$10M | 583.77K | – | SEC |
| – | Jan 30, 20234:30 PM ET | Jan 26, 2023 | Avoro Capital Advisors LLC and 1 other10% Owner | PPurchaseCommon Stock · Derivative | +2.14M | $6.9999 | +$15M | 2.14M | – | SEC |
| – | Nov 23, 20214:15 PM ET | Nov 22, 2021 | Avoro Capital Advisors LLC and 1 other10% Owner | PPurchaseCommon Stock · Derivative | +2.5M | $3.9999 | +$10M | 2.5M | – | SEC |